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 Abstract 
In the last ten years, interest in manipulating droplets in microchannels has emerged from two 
important motivations. The first arise from the desire to produce well controlled droplets for 
material science applications, for example in the pharmaceutical or food industries. In this 
context, microfluidics allows for producing such droplets in a controlled and reproducible 
manner, also allowing complex combinations to be designed and explored. A second 
motivation originates with the advent of the -omics era, which has a much need for being able 
to carry out experiments at the smallest possible scale (if possible single cells or molecules), 
on a massively parallel platform and with high throughput. In this case, droplets are viewed as 
micro-reactor in which samples are confined, and which offer a way to manipulate small 
volumes.  
Droplet microfluidics is the most powerful microfluidic technology used to produce and 
manipulate monodisperse droplets. This technique addresses the need for lower costs, shorter 
times, and higher sensitivities to compartmentalize reactions into picolitre volume, instead of 
the microlitre volumes commonly used with standard methods.  
Droplets can provide a well-defined environment into which individual cells can be 
compartmentalized in a controlled way. This coupled with the advantages of droplet 
microfluidics has allowed the development of several methods for single-cells analysis. In this 
work a microfluidics label-free approach for circulating tumor cells (CTCs) detection is 
presented. In the last decades, CTCs have received enormous attention as a new biomarkers 
for cancer study, for this reason their capture and retain represents a major challenge in cancer 
research. Many issues regarding the detection and characterization of CTCs are owing to their 
extremely rarity (one CTCs for 5 x 10
9 
erythrocytes/mL and for 7 x 10
6
 leucocytes /mL) and 
their heterogeneous nature (there is no unique biologic marker for CTCs identification). 
Although much promising progress has been made in CTCs detection, the robustness in 
distinguishing between healthy cells and CTCs, and the isolation of live CTCs need to be 
improved further. The method developed in this work exploits the so-called Warburg effect 
(WE): even in the presence of oxygen cancer cells limit largely their metabolism to glycolysis 
leading to increased production of lactate. Using droplet microfluidics, cancer cells are 
compartmentalized into a picolitre droplets and lactate secreted by cells are retained in the 
droplet. The secretion of lactate leads to a rapid increase in the concentration of acid in cell-
containing droplets. CTCs are thus detected by monitoring the pH of the droplet using a pH-
sensitive dye, without the need for surface-antigen labeling. A suspension of tumor cells 
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(A549) mixed with white blood cells were emulsified in picoliter droplets, and it was 
observed a clear fraction of droplets with a reduced pH, leading to a distinct population of 
droplets containing a cancer cell from empty or WBC containing drops. With this method a 
very few number (up to 10) of tumor cells in a background of 200,000 white blood cells are 
detected, with average detection rates in the range of 60%. To demonstrate that this is a 
general method for detection of cancer cells, several cancer cell lines were tested, including 
ovarian TOV21G, breast MDA-MB 453, glioblastoma U231, colorectal HT-29, breast MCF-7 
and MDA-MB-231  and all showed acidification of droplets. With the method established, 
samples based on blood cancer patients with confirmed metastatic disease were tested. The 
results show clearly that numerous positive droplets are detected in the sample of metastatic 
patients. Moreover, this method is capable of retrieving live cells, opening up routes for 
further large scale investigation of the nature of CTCs. 
Another interesting area where droplet-based microfluidics is playing an increasingly 
important role is the synthesis of functional polymeric microparticles or microgels. They have 
been suggested as diagnostic tools for the rapid multiplexed screening of biomolecules, 
because of their advantages in detection and quantification.  
In the second part of this thesis, the synthesis of polymeric microparticles, functionalized with 
peptides, through droplet microfluidics is presented. Peptide was efficiently encapsulated into 
the polymeric microparticles in order to create a functional microparticles for selective protein 
detection in complex fluids. Protein binding occurred with higher affinity (KD 0.1-0.4 µM) 
than the conventional detection methods (KD 70 µM). Current work demonstrate easy and fast 
realization of functionalized monodisperse microgels using droplet microfluidic and how the 
inclusion of small molecules within polymeric network improve both the affinity and the 
specificity of protein capture. This work provides advances in gel particle functionalization 
and opens new possibilities for direct molecules detection in complex fluids. A possible 
application of this method was for label-free aflatoxin M1 (AFM1) detection. AFM1 is the 
most toxic, carcinogenic, teratogenic and mutagenic class of aflatoxins (AFs) and can be 
present due to <fungal contamination> in a wide range of food and feed commodities, such as 
milk and dairy products, representing an important issue especially for developing countries. 
Currently, the detection methods used to quantify AFM1 require complex and laborious 
sample pretreatments, expensive instruments and skilled operators, thus limiting their 
application. Driven by the need of overcoming some of these limits, poly(ethylene glycol) 
dyacrilate (PEGDA) functional microparticles were produced using  microfluidics. Two novel 
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peptides were synthesized for specific aflatoxin detection and encapsulated in PEGDA 
microparticles for AFM1 detection. AFM1-binding peptides occurred with high affinity (KD 
3.66-6.57 pM, respectively for the two sequences) and detection was achieved measuring 
AFM1 innate fluorescence. The detection limit of this technique for AFM1 was estimated to be 
1.64 ng/Kg, with a dynamic detection range between 3.28 ng/Kg and 70 ng/Kg, which meets 
present legislative limits of 50 ng/Kg for AFM1 in milk. Therefore, the developed systems 
provides a promising approach for rapid screening of food contaminates because it resulted to 
be simple, sensitive, specific, and with not need multiple separation steps, overcoming the 
limits of the traditional AFM1 detection methods, which are expensive and time consuming. 
The use of microfluidics has allowed development of robust, label-free, sensitive and high-
throughput platforms which may be used in the near future to improve the quality of life. 
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CHAPTER 1  
 
 
 
 
General introduction  
and thesis outline 
 
 
 
 
 
 
 
 
 
Academics like complexity and emergency. The real world puts up with it reluctantly, but 
really wants simplicity…. 
…whatever simplicity is. 
(G. Whitesides). 
 
 
 
 
You know you’ve achieved perfection in design, not when you have nothing more to add, 
but when you have nothing more to take away.  
(de Saint-Exupery) 
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1.1 Microdroplets in Microfluidics: an evolving platform  for 
cell biology and sensing 
In 1954 Joshua Lederberg published a “simple method for isolating individual microbes”1, 
demonstrating the compartmentalization of single cells into nanoliter droplets. However, 
although the basic ideas of compartmentalization of cells and the study of enzymatic 
reactions in microdroplets were demonstrated, it has taken almost 50 years for Lederberg’s 
vision to become reality. With the advent of the -omics era there is an apparent need arisen 
for being able to carry out experiments at the smallest possible scale (single cells or 
molecules), on a massively parallel platform and with high throughput
2
. Recent advances 
in microfluidics have enabled the development of powerful tools for manipulation small 
amount (10
-6
 to 10
-12
 litres) of volume in channels at length scales of tens to hundreds of 
micrometers
3
. Microfluidics coupled with the technologies developed by the micro-
electromechanical systems (MEMS) field have provided the possibility to build up 
extremely reproducible and well defined fluidic chips, commonly referred as micro-total 
analysis systems (uTASs)
4,5
 or Lab-on-a-chip (LOC). This combination has resulted in a 
rapidly growing interest by researches to use microfluidic microdroplets for cell biology 
and biosensing applications
2,6-8
. The key features of microparticles in microfluidics are that 
they are monodisperse in size and therefore potentially suitable for carrying out 
quantitative studies, provide a compartment in which species can be isolated, provide the 
possibility to work with extremely small volumes and single cells or molecules, and offer 
to perform very large numbers of experiments
2
 (figure 1.1). These specific features have 
enabled the use of microdroplets as tools for discoveries in cell biology and bio-detection. 
  Chapter 1  
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Figure 1.1: Microdroplets in microfluidics: A) microdroplets for single-cells analysis; B); C) 
droplet microfluidics for functional microparticles production; D) Dual fluorescence colloid-filled 
hydrogel granules (“Janus” particles). Reproduced with permission from ref []   
 
 
1.1.1 Key characteristics of microdroplets in microfluidics  
Compartmentalization, monodispersity, small, fast reactions 
The compartmentalization of reactions in microdroplet can be applied to a very wide range 
of experiments, chemical or biological. For example, in experiments where droplets 
contain single cell or living organisms, the environment of the cell can be controlled and its 
changes can be measured and studied. Microdroplets prepared through microfluidic 
platforms are highly monodisperse, with polydispersities in the range of 1 %  (in 
diameter)
9,10
. Thus every experiment took place in the same volume, controlling the 
concentration of reagents and reaction products. Furthermore, the analysis of reactions in 
bulk emulsions by screening individual droplets takes a considerable amount of time and 
therefore every droplet is analyzed at a different reaction time. With microfluidics, the 
screening is not much faster, but the rank order of droplets can be maintained and so every 
droplet has the same time lag between formation and screening. Additionally, droplets can 
be analyzed directly on-chip using integrated techniques, such as fluorescence detection, so 
they can be analyzed at controlled times
11-13
. The advantage of microfluidic technologies is 
crucial: as monodisperse droplets are formed on-chip and reactions are initiated at the point 
of drop formation or by droplet fusion, every droplet is identical in terms of concentrations 
and time-analysis. This has an important advantage in single-cell or single-molecule 
  Chapter 1  
10 
 
studies, where stochastic variations require the detailed analysis and combination of data 
from large numbers of experiments
14
. 
Typical droplet volumes are in the nanoliter (nL) to picoliter (pL) range. As a result, 
reagent consumption is extremely small, allowing for the screening and analysis of 
precious compounds. Controlling the volume of droplets, the ability to tune the 
concentration of macromolecules in droplets also provides an ideal platform for exploring 
optimum conditions for protein crystallization
12,15
. Moreover, the confinement of a single 
cells in droplets allows released molecules to accumulate in a small compartment, their 
concentration hence rapidly increases into droplet, and the time required to detect the 
released molecules is reduced
16
.  
 
1.2 Droplet microfluidics 
Droplet-based microfluidics involves the generation and manipulation of monodisperse 
droplets, which can serve as compartments for single cell analysis or can be polymerized 
into polymeric microparticles for diagnostics and biosensing
17
. Unlike continuous flow 
systems, droplets enable isolated reactions to be performed in parallel without cross-
contamination or sample dilution. Microfluidic droplet-based systems represent a high-
throughput platform for biological and chemical research
18,19
. The formation of droplets 
can be done with passive mechanisms, such as with co-flowing streams, cross-flowing 
streams in a T-shaped junction, and elongation flow in a flow focusing (FF) geometry
20
 
(figure 1.2) or with active electrohydrodynamic (EHD) mechanisms, such as 
dielectrophoresis (DEP)
21
 and electrowetting on dielectric (EWOD)
22
.  
 
 
Figure 1.2: Standard geometries used for controlled droplet formation in microfluidic devices – T-
junction, Flow-focusing Device (FFD) and Co-flow. Reproduced with permission from   
Generally, two immiscible liquids such as a hydrophilic solution and hydrophobic oil are 
combined at a rate in which the shear force at the fluid interface is sufficiently large to 
cause the continuous phase to break the aqueous phase into discrete droplets
23,24
. The 
dimensionless Capillary number (Ca) plays a key role in droplet break-off. Droplet 
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formation is driven by the competition between the viscous stress and the surface tension 
of the two immiscible fluids, and occurs at a critical Ca:    
   
 
, where  [Pa-s] and U0 
[m/s] are the viscosity and velocity of the continuous phase, respectively, and  [N/m] is 
the interfacial tension between the immiscible phases
25,26
. Above a certain critical capillary 
number, droplet break off occurs. A low value of Ca indicates that the stresses due to 
interfacial tension are strong compared to viscous stress. Drops flowing under such a 
condition nearly minimize their surface are by producing spherical ends. In the opposite 
situation of high Ca, viscous effects dominate and one can observe large deformations of 
the drops and asymmetric shapes
26
. It is important to note that the critical capillary number 
is system dependent as different values have been reported by various groups using 
different geometries. To realize this number, it is important to consider the relative 
viscosity between the two phases. Selection of a more viscous hydrophobic phase will 
facilitate formation of droplets
20
. For example, for water-in-oil (W/O) emulsion, 
hydrophobic phase commonly consists of oils, which tends to be naturally more viscous 
than water. The immiscibility of the two-phases ensures the isolation and 
compartmentalization of each phase. 
Passive droplet generation techniques are ideal for experimental conditions where a large 
number of droplets are desired, namely for high-throughput or parallel analysis 
applications, such as large-scale PCR
27
 or culturing techniques
28
. Furthermore, the 
composition of the neighboring droplets can be controlled by adjusting the relative 
concentration of the upstream aqueous solution. This is especially useful for chemical 
analysis applications, such as enzymatic assays
29
, drug discovery assays
30
 and protein 
crystallization techniques
12
. 
 
1.3 Droplet microfluidics applications  
The high control and integrative ability available for operating and manipulating droplets 
make droplet microfluidic technology ideal for biomedical and biotechnology applications. 
In particular, the areas where droplet-based microfluidic platforms are playing an 
increasingly important role and of interest for this thesis are the analysis at single cell level 
and the synthesis of functional hydrogel microparticles for biosensing and detection
31
.    
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1.3.1 Droplet microfluidics: a tool for single-cells analysis 
Droplet microfluidics allows the isolation of single cells in a well-defined (potential sterile) 
environment and the manipulations at a throughput of thousands of droplets per second
32
. 
A strong advantage of analyzing single cells in droplets is the ability of rapid detection of 
cell-secreted molecules due to the low volume surrounding each encapsulated cell, thereby 
overcoming one of the major limitations of traditional flow cytometry (FC) and 
fluorescence-activated cell sorting (FACS)
33
. In addition, in microfluidic systems, droplets 
can be merged with other droplets
34
, split into two
35
 or dielectrophoresis (DEP)-sorted
36
 for 
further analysis.  
The growing of emerging technologies have enabled to integrate electrodes into 
microdevices providing electrical control over droplet motion and manipulation
20
. For 
examples the integration of DEP-based sorting in droplet microfluidics has allowed to 
retrieve a specific subset of droplets from the rest of the droplet stream. The retrieval of a 
small population of cells for further analysis is a crucial step in cases of circulating tumor 
cells, hybridoma production or drug screening. Recently, DEP combined with laser-
induced fluorescence (LIF) technique has allowed to separate target droplets from the rest 
of the droplet stream with electric fields according to their fluorescent content, thereby 
isolating the droplets of interest
36-38
. LIF is a spectroscopy method that offer very sensitive 
and ultra fast detection in many applications such as cell-based assays, PCR detection and 
binding assay
39
.  
Griffiths, Weitz and coworkers showed an example of integrated on-chip fluorescent-
activated droplet sorting system, based on DEP-sorting, for high-throughput analysis of 
single cells (figure 1.3). They described a binding assay to detect antibodies secreted from 
single mouse hybridoma cells. Secreted antibodies were detected by co-
compartmentalizing single mouse hybridoma cells, a fluorescent probe and single beads 
coated with anti-mouse IgG antibodies in 50 pL droplets. When the binding occurs a 
clearly distinguishable signal of fluorescence inside droplet is generated and recorded by 
laser. If the intensity of the fluorescence is above a preselected threshold such droplet is 
actively sorted via DEP
40
.  
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Figure 1.3: Integrated on-chip fluorescent-activated droplet sorting system, based on DEP-sorting, 
for high-throughput analysis of single cells. Three steps are describe:1) cells encapsulation; 2) 
droplets containing cells reinjection in a second device; 3) droplets containing green fluorescent 
beads are sorted using a fluorescence activated droplet sorter. Reproduced with permission from 
Ref [40] 
Single cell is the fundamental component of life, therefore, single-cell analysis in not just 
one more step towards more-sensitive measurements, but is a decisive jump to a more-
fundamental understanding of biology
41
. For a long time it is assumed that cell cultures 
were of homogeneous nature, and analyze a collection of cells would give an accurate 
assessment of the behavior of the cells in that culture or tissue. This means that the average 
response of the cells can be interpret as the response of the all cells in that sample
42
. Thus, 
droplet microfluidics certainly plays a significant role in elucidating the heterogeneities of 
cell populations and their underlying causes, finding the rare cells that average only a 
single cell per milliliter of blood. Droplets features allow many of the challenges in single-
cell analysis to be overcome
43
. There are of course challenges with integration as the 
droplet microfluidics circuitry becomes more complex, nevertheless droplet microfluidics 
has the potential to support scientific progress in further analysis of the fundamental 
component of life- the cell. 
1.3.1.1 Circulating tumor cells detection 
Circulating tumor cells are small amount of cells shedding into bloodstream from both 
primary and metastatic lesions and are thought to be responsible for the hematogenous 
spread of cancer to distant sites
44-46
. Strong evidence for CTCs as prognostic markers has 
been documented for breast cancer
47
, but CTC detection is also connected to metastatic 
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relapse and progression in other tumor entities, including prostate, lung and colorectal 
cancer
48-51
. In ongoing studies, the clinical utility of CTCs for treatment decisions is being 
evaluated
51
. In particular the use of CTCs as a real-time liquid biopsy has received 
attention during the past years
52. In addition, their capture directly from a patient’s blood is 
a non invasive method for cancer detection. However, the capture of CTCs from a patient’s 
blood with high efficiency and purity is still a technical challenge. The capture and 
analysis of CTCs is very difficult owing to the low levels of these cells in blood
53
 
(approximately one CTC in a billion blood cells is seen in cancer patient blood). Moreover, 
the heterogeneous nature of CTCs poses an additional challenge, as there is no unique 
marker for their identification
53-56
. Furthermore, in order to carry out cell culture and 
molecular analysis of the CTCs, their capture are expected to be kept viable.  
Various techniques have been recently explored to isolate CTCs from patient blood (figure 
1.4) in which microtechnologies devices and materials have been demonstrated as possible 
solutions
57
.  
 
Figure 1.4: CTC separation methods. A) Immunoaffinity purification; B) Aptamer-based 
separation; C) Nanorough surfaces; D) Microfi lters; E) Hydrodynamic separation; F) 
Dielectrophoresis; G) Approaches integrating multiple CTC capture principles together. 
Reproduced with permission from  Ref [57] 
At the moment the only system commercially available which gets approval from the US 
Food and Drug Administration (FDA) for CTC analysis is CellSearch. It is an 
immunomagnetic enrichment method that relies on targeting a marker specific to epithelial 
cells, the epithelial cell adhesion molecule (EpCAM). However CellSearch has a number 
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of limitations, for examples has a lack of sensitivity that limits its applicability to the 
analysis of cells with high EpCAM levels
58,59
, and not all CTCs present high EpCAM-
expression. An additional constraint is the inability to access cellular material after cells 
are enumerated. To this end it is necessary develop technologies that have to be efficient 
enough to recover as many CTCs as possible thus ensuring the enumeration process 
reflects the status of the cancer patient and guarantees enough CTCs for the post-capture 
analysis to study the cancer metastasis process. Separation methods should be therefore 
able to release CTCs without damaging them and need to be less time-consuming and be 
able of conducing high-throughput separation, due to the short life of CTCs
60
. Finely, these 
technologies must be effective for most types of cancer patients and cancer at different 
disease stages. 
 
1.3.2 Droplet microfluidic: a platform for functional 
microparticles production for detection applications. 
Droplet microfluidic techniques provide some of the most promising approaches to 
produce and functionalize monodisperse polymeric microparticles
61
 for biosensing and 
detection (figure 1.5).  
 
Figure 1.5: Functional microparticles tailored by droplet-based microfluidics. Reproduced with 
permission from Ref. [61] 
These microparticles are obtained through the polymerization of the emulsion 
microdroplets template, generated by microfluidic device. Polymerization can be perform 
via different mechanisms: heat-based, light-based and chemical-reaction-based methods
17
. 
In all cases the discrete phases are comprised of a thermally, photochemically or 
chemically curable material that can be converted into solid microparticles under specific 
stimuli.  
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Polymeric microparticles can be functionalized employing creative strategies in droplet 
microfluidics, which are difficult to achieve using conventional suspension. For example, 
they can be engineered with diverse biological entities such as peptide, protein or nucleic 
acids
62
 to detect proteins, DNA, mRNA, microRNA in complex fluid
63
. 
A few reports investigated the synthesis of enzyme-immobilized hydrogel microparticles 
and their ability for the biosensing of small molecules
64
. For example, in 2012 Kantak et al. 
used microfluidic T-junction to generate poly(ethylene) glycol (PEG) microparticles, 
containing fluorescein isothiocynate dextran (FITC-dextran) and a sugar binding protein, 
for a fluorescence-based glucose detection assay
65
.  
1.3.2.1 Poly(ethylene glycol) (PEG) microparticles 
Polyethylene glycols (PEG) (figure 1.6) are commonly used in biotechnological 
applications due to their biocompatibility and low-biofouling properties
62,66-68
. In 
particular, PEG layers have been used to prevent non-speciﬁc binding of protein on sensing 
surfaces
69,70
.  
 
Figure1.6: Polyethylene glycols (PEG) 
PEGs are relatively inexpensive and available in a large range of molecular weights and 
chemical modiﬁcations: PEG molecular weights ranging from a few hundred to several 
thousand grams per mole have been used to fabricate particles
71
. Conveniently, PEGs show 
good solubility in aqueous buffers required for biomolecule manipulation and PEG 
particles have thus been the substrate of choice for hydrogel particle-based assays so far. 
PEG microparticles are usually prepared using the free-radical polymerization of reactive 
(meth)acrylate PEG derivatives or polyethylene glycol diacrylates (PEGDA) in the 
presence of a UV-sensitive photoinitiator
72-74
. The UV-induced activation of the 
photoinitiator generates a benzoyl free radical through a homolytic scission of a C–C bond, 
subsequently triggering the covalent crosslinking of the gel
75
. 
One immunoassay on PEG microparticles was reported by Appleyard et al. in 2011
76
. The 
authors developed a complete sandwich immunoassay for multiplexed detection of 
cytokines on barcoded poly(ethilenglycol) dyacrilate (PEGDA) particles synthesized 
through microfluidic device. Target samples were spiked in fetal bovine serum (FBS) in 
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order to mimic the complexity of biological samples. The bio-inert poly PEG hydrogel did 
not collect non-speciﬁc signal in these complex samples, avoiding the need for prior 
puriﬁcation of the sample.   
1.3.2.2 Microfluidics for food analysis: aflatoxin M1 
Microfluidics is a technology that allows constructing small, fast and cheap microfluidic 
analytical systems for food analysis
77
. The presence of a variety of food contaminants and 
residues at low concentration, their difference in physicochemical behavior and the 
complexity of the food matrix make food analysis a challenging task. Chromatographic 
techniques are commonly used in food analysis
78
, however they are relative slow, require 
extensive sample preparation and need trained personnel. As a consequence, they are 
expensive and time consuming for routine analysis.  
The need for cheap and high throughput has encouraged the development of new 
technologies and more suitable analytical methods
79
.  
In the last two decades, one of the major challenges in the field of food analysis, is the 
detection of aflatoxins (AFs). AFs are a major class of mycotoxins produced primarily by 
Aspergillus species
80
. Aflatoxin M1 (AFM1) is the most toxic, carcinogenic, teratogenic 
and mutagenic class of AFs
81
; it is a hydroxylated metabolite of aflatoxin B1 (AFB1) 
(figure 1.7) and it is normally excreted in milk by dairy mammals as a result of the direct 
intake of AFB1–contaminated feedstuff.  
 
Figure 1.7: aflatoxin B1 metabolism 
AFM1 has been classified as a Group 1 carcinogenic agent by the International Agency 
for Research on Cancer in 2002 (IARC 2002). Once present in milk, AFM1 is unaffected 
by thermal treatments, such us pasteurization or sterilization
82
. In 2006, the European 
Union (UE) set the legal limit for AFM1 to 0.05 µg/Kg. This has prompted the adoption of 
regulatory limits in several countries, which, in turn, requires the development of validated 
official analytical methods for rapid and cost-effective screening of AFM1 on a large scale. 
Various analytical methods and strategies have been applied for the detection of AFM1, 
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e.g., thin-layer chromatography (TLC), HPLC, gas chromatography (GC), liquid 
chromatography−mass spectrometry (LC-MS), enzyme-linked immunosorbent assay 
(ELISA), direct fluorimetry, fluorescence polarization, and various biosensors/lateral flow 
devices (LFD)
83-88
. However, it is known that these methods not only require expensive 
instruments and skilled operators but also complicated sample pretreatment thus limiting 
their application, especially in developing countries
89
. In this perspective, the use of 
droplet-based microfluidics coupled with the use of biorecognition elements (such as 
enzymes, peptides and antibodies) could realize simple and low cost platform for 
aflatoxins detection. 
1.4 Outline of Dissertation 
Microfluidics is an increasingly tool for single-cells analysis and also for functional gel 
microparticles production. We use droplet microfluidics to study rare cancer cells and to 
synthesize polymeric microparticles for selective protein detection in complex fluid. The 
final aim of this work concerns the realization and the optimization of microfluidic 
technologies for the development of diagnostics tools for personal care and of relative 
simple and rapid system for food contaminants detection.  
In Chapter 2 a microfluidics approach for circulating tumor cells (CTCs) detection, based 
on single-cell metabolism determination, is presented. Droplet microfluidics is used to 
compartmentalize each cell inside a picoliter droplet and lactic acid production by 
compartmentalized cancer cells is detected by monitoring the pH of the droplet through 
LIF at approximately 1kHz. The results are promising, and open the routs for further work 
in vivo.  
In Chapter 3 droplet microfluidics for functional microgels synthesis, for biosensing 
application, is presented. A labeled peptide was encapsulated into microparticles for 
specific molecules detection in complex media. The encapsulation of the peptide increase 
the specificity and the sensitivity of the biomolecules detection, providing an advantage in 
biotechnological field.  
Finally, in Chapter 4, microfluidic microparticles for label-free AFM1 detection is 
presented.  The same method described in Chapter 3 is used for the production of 
functional PEGDA-microparticles for AFM1 screening. Two novel peptides, synthesized in 
our laboratory for specific aflatoxin recognition, were encapsulated into the polymer 
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network. Due to AFM1 natural fluorescence, the efficacy of the method was provided by 
CM.  
Final conclusions and future perspectives, with some parameters that still need to be 
optimized are synthetically presented and discussed in Chapter 5. 
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2. CHAPTER 2 
 
A microfluidic approach for single-cell  
metabolism determination, a tool for circulating tumor cells 
detection 
Abstract. The number of circulating tumor cells (CTCs) in blood is strongly correlated 
with the progress of metastasic cancer, for this reason their capture and retain represents a 
major challenge in cancer research. Traditional methods to isolate and characterize CTCs 
are based on immunostaining or discrimination of physical properties. Recently 
microengineered devices have been demonstrated as a possible solution to capture and 
processing of CTCs. Here, a label-free method is presented. It exploits the so-called 
Warburg effect (WE): even in the presence of oxygen cancer cells limit largely their  
metabolism to glycolysis leading to increased production of lactate. Cells are 
compartmentalized into a pL droplets using droplet microfluidics. Cancer cells secrete 
lactic acid faster than healthy cells, acidifying the extracellular environment. The lactic 
acid production can be detect by monitoring the pH changes within droplets. Cancer cells 
are detected by finding droplets with significant pH changes. This method is capable of 
retrieving live cells, opening up routes for further large scale investigation of the nature of 
CTCs.   
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2.1. Introduction 
The progression of cancer from a localized tumor to metastasis is central to  often 
devastating effects of this complex illness. A release of CTCs from primary tumor into the 
bloodstream is one of main routs for the formation of metastases in distant organs
1
.CTCs 
that posses an aggressive phenotype can invade a healthy tissue and form secondary 
tumors, which are often cause of patient's death. A recent clinical research has shown that 
level of CTCs in metastatic patient's blood is a predictor of survival, indicating the value of 
CTCs as a biomarker for cancer diagnosis, prognostic outcome evaluation, and treatment 
monitoring
2-5
. Therefore, the isolation and the analysis of CTCs has a potential to provide 
an insight in blood-born metastasis and monitor cancer response noninvasively following 
therapeutic intervention.  
The capture and analysis of CTCs is very challenging owing to their extreme rarity relative 
to erythrocytes (5 x 10
9 
cells/mL) and leucocytes (7 x 10
6
 cells/mL) in patient's blood
6
. 
Although red blood cells can be easily removed by lysis, leucocytes (white blood cells) 
share many of the physical, chemical and biological properties of CTCs, leading to high 
contamination levels in many CTC detection methods
7
. The heterogeneity of CTCs poses 
an additional challenge, as there is no unique biologic marker for their identification
8,9
. 
Biochemical techniques for detection and enumeration of CTCs exploit the presence of 
surface and cytoplasmic proteins (epithelial cell adhesion molecule (EpCAM), HER2, 
EGFR, MUC1, or CKs) that are not present in leukocytes
10
. Currently the only clinically 
validated method (CellSearch®) is based on the enumeration of epithelial cells that are 
separated from the blood by EpCAM-coated magnetic beads and identified with the use of 
fluorescently labelled antibodies against cytokeratin (8, 18, 19) and with a fluorescent 
nuclear stain
11
. CellSearch® and other methods base on immunostaining are able to detect 
reliably EpCAM-positive CTCs. However, a potential problem for detection of EpCAM 
positive CTCs is the variation of EpCAM expression in cancer cells. When detached from 
the primary tumor, metastatic tumor cells may experience the epithelial-to-mesenchymal 
transition (EMT), which leads to the disappearance of epithelial features such as EpCAM 
expression, and such approaches using the EpCAM biomarker may result in the loss of 
partial populations of CTCs, which may have more aggressive metastatic potentials
12,13
. To 
overcome this limitation alternatives methods based on physical properties such as the 
mechanical properties of CTCs, size, deformability, or electric charge, have been 
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developed. They are low cost, label-free and, most importantly, permit significantly higher 
throughput compared to immunostaining-based methods. While these techniques achieved 
satisfactory isolation efficiency, the viability of the captured CTCs was compromised. 
Moreover, morphological analysis of CTCs has shown that the size of these cells varying 
from 4 to 30 µm, thus some CTCs could be as large as leukocytes, resulting in a potential 
loss of subpopulations of CTCs
14
. 
Although significant progress for CTCs detection has been made, further improvement is 
necessary. Methods capable of detection and isolation of live, intact CTCs will open 
opportunities for detailed analysis of CTCs and metastasis.  
In the 1920s Otto Warburg observed an anomalous metabolism of cancer cells for the first 
time
15.
 Even in the presence of oxygen cancer cells limit largely their metabolism to 
glycolysis leading to increased production of lactate, phenomenon that has been termed 
“Warburg effect” or “aerobic glycolysis”16. An altered metabolism of cancer cells (and 
associated extracellular acidification via various mechanisms) is widespread across 
different types of cancers, and it  has been accepted as a hallmark of cancer
17
. The 
Warburg-correlated upregulation of glucose uptake is well-known, and forms the basis of 
F-fluorodeoxyglucose Positron-Emission Tomography (FDG-PET), currently applied in 
the diagnosis, staging and monitoring of almost all types of cancer
18
.  Although the 
Warburg effect has been known for over 50 years, it has never been used to detect CTCs, 
as such cells are so rare that they do not noticeably alter  lactate levels in  blood.  
Here we present a label-free method for CTCs detection exploiting the abnormal metabolic 
behavior of cancer cells (WE) using droplet microfluidics. A suspension of tumor cells 
from a cancer cell line (lung - A549) were emulsified in 35 pL droplets. All molecules 
secreted by cancer cell are retained in the droplet and concentration of secretion product 
rapidly increases due to the small volume of the droplets. Thus CTCs are detected by 
measuring lactate or pH changes in the extracellular compartment without the need for 
surface-antigen labeling. We then mixed A549 cells with white blood cells (WBCs), as 
these will be the primary background in blood samples taken from patients, and observed a 
clear ~ 2 fold intensity difference between droplets containing cancer cells and empty or 
WBC containing drops (Figure 2.1).  
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Figure 2.1: schematic representation. A) lactate secretion by CTCs provide an acidification of 
extracellular environment; B) different of fluorescent between droplets contain cancer cells and 
empty or WBC containing drops; C) detection of environment acidification due to lactate secretion 
via pH measurement. 
 
2.2. Results and discussion 
2.2.1. Characterization using cell lines 
The key technological breakthrough presented here lies in splitting the macroscopic 
(blood) sample into small (picoliter-nanoliter) aqueous droplets in oil (water-in-oil 
emulsion) using droplet microfluidics
19
. Each droplet contains at most a single cell and all 
molecules secreted by this single cell are retained by the droplet
20
. To establish the validity 
of our approach, we emulsified a suspension of tumor cells from a cancer cell line (lung - 
A549) in 35 pL droplets in the presence of culture medium and a lactic acid assay mixture. 
The number of cells in each droplet followed a Poisson distribution ensuring >90% single 
cell encapsulation (Figure 2.2) and we demonstrated the production of lactate by A549 in 
drops.  
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Figure 2.2: distribution of cell occupancy in droplets. Distributions shown for emulsification of 1 
000 000 cell/mL (A) and 5 000 000 cell/mL (B). By far the majority of droplets are empty, but 
more than 90% of droplets containing cells have only 1 cell per droplet. 
In order to simplify the assay, we measured lactate secretion indirectly, by monitoring the 
pH of the droplet using a ratiometric pH-sensitive dye (Snarf-5F). Figure 2.3 clearly show 
a difference in fluorescent intensity, that means a drop in pH inside droplets, between 
empty droplets, droplets containing cancer cells or containing WBCs. There is some spread 
in the fluorescence. This variation is most likely due to a difference in lactate secretion 
rates between individual cells. 
 
Figure 2.3: detection of acidification due to lactate secretion via pH measurement. pHrodo Green 
dye was used to indicate pH changes. Results are comparable to lactate assay and confirm the 
difference between cancer cells and WBCs. 
To screen droplets with higher throughput in a semi-automated way, we engineered an 
inverted microscope, so that each droplet can be analyzed using laser-induced fluorescence 
at approximately 1 kHz
21,22
 (Figure 2.4). For each droplet the ratio of emitted fluorescence 
at 580 and 630 nm is calculated in real time. In the presence of cell secreting lactate the pH 
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inside a droplet reduces below 7.4 and as a result an increase in 580/630 ratio above 1 is 
observed (Figure 2.4A). 
 
 
Figure 2.4: Detection of CTC using dual emission SNARF 5F dye. (A) Fragment of a raw data 
trace. Inset shows micrograph of a detected CTC. (B) Schematic of experimental setup.: laser-
induced fluorescence setup. 
Real time analysis of each droplet enables us to capture images (Figure 2.4A) of a subset 
of droplets with increased 580/630 fluorescence ratios, thus providing an additional 
verification. The assay consists of three steps: a sample emulsification, incubation and a 
readout. To facilitate subsequent reinjection step droplets were generated, collected and 
incubated in a device with a cone-shaped chamber. After incubation all droplets are 
injected in another device where each droplet is interrogated and fluorescence ratio is 
determined. 
We made a calibration curve of Snarf-5f to correlate fluorescence intensity (ratio between 
fluorescence intensity at 580 nm and intensity at 630 nm) with pH changes inside droplets 
(Figure 2.5). A set of Joklik’s modified EMEM solutions was prepared and titrated to 
various pHs between 7.4 and 5. These solutions were emulsified and ratio of obtained 
droplets detected similarly to A549 samples. 
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Figure 2.5: calibration of SNARF-5F response. Ratio between fluorescence intensity at 580 nm 
and intensity at 630 nm. 
2.2.2. Outperforming other methods 
Using the developed method, we investigated secretion in various cancer cell lines. The 
secretion of lactate leads to a rapid increase in the concentration of acid in cell-containing 
droplets. Even after short incubation times (<2 minutes) a population of acidified droplets 
appears. This population increases further, approaching saturation after 10-20 minutes. 
Therefore, all our experiments were carried out using incubation times of at least 10 
minutes (Figure 2.6).  
 
Figure 2.6: (Top panels) Dot plots showing a population of droplets becoming increasingly acid 
over time. (Bottom panel) A fraction of droplets reaching certain ratio (>1 – green trace; >1.5 – red 
trace) 
0,5 
1,0 
1,5 
2,0 
2,5 
3,0 
3,5 
4,0 
4,5 
5 5,5 6 6,5 7 7,5 
R
at
io
 
pH 
  Chapter 2  
42 
 
To demonstrate that this is a general method for detection of cancer cells, we tested several 
other cancer cell lines, both EpCAM(+) and (-) including ovarian TOV21G, breast MDA-
MB 453, glioblastoma U231, colorectal HT-29, breast MCF-7 and MDA-MB-231 - and 
found that all show acidification of droplets (Figure 2.7). The results makes our method 
suited to study a range of cancer types. These include epithelial cancers in which activation 
of EMT during cancer cell invasion triggers loss of epithelial markers, as well as non-
epithelial cancers such as melanoma. 
 
Figure 2.7: metabolic response of selected cancer cell lines. WBC response is given for 
comparison. 
2.2.3. Optimization: A549 mixed to WBC for clinical samples 
simulation 
We used A549 cell line mixed with WBCs to simulate clinical samples and to investigate 
analytical figures of merit of the developed method. Experiments were then repeated using 
larger numbers of cells. Figure 2.8A shows data points for 2 millions droplets of an 
emulsified A549 suspension, and we see a clear fraction of droplets with a reduced pH. 
Figure 2.8B shows data points for 2 millions droplets produced from a sample of WBCs 
from a healthy donor; visual inspection of the captured image of the few acidic droplets 
detected never confirmed the presence of WBCs. Figure 2.8C shows data points for 2 
millions droplets of the same sample with A549 cells spiked in, leading to a distinct 
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population of acidified droplets. These figures clearly demonstrate that our method is 
capable of distinguishing healthy cells from metabolically active A549.  
CTCs are extremely rare cells and the detection of these cells requires an assay with high 
sensitivity and specificity. To quantify both, we emulsified mixtures of A549 tumor cells 
with WBCs in ratios ranging from as few as 10 : 200,000 to 130 : 200,000 A549:WBC 
(total samples sizes containing 1M/mL WBCs). Figure 2.8D shows the number of tumor 
cells detected vs. number of tumor cells spiked in. Our method is capable of detecting 
A549’s even at the lowest dilutions tested, with average detection rates for all experiments 
in the range of 60%. We note that at low cell count, deviations between expected and 
recovered cell numbers might be due to variations in actual cells compartmentalized, and 
losses due to adhesion to tubing or syringe. Importantly, none of the low pH droplets 
contained WBCs (as confirmed by analyzing the video images). 
 
 
Figure 2.8: Detection of A549 cells. (A) A 549s alone in Joklik medium (pH 7.3). (B) isolated 
WBC alone in medium. (C) Mixture of A549 and WBCs in medium. (D) Absolute and relative 
recovery of spiked A549 in presence of WBC. 
2.2.4.  Capture of cancer cells from blood sample of patients 
With the method established, we tested samples based on blood of healthy donors as well 
as cancer patients with confirmed metastatic disease. To be able to process a large amount 
of blood, we depleted lysed blood of CD45+ cells by magnetic labeling (Miltenyi Biotec). 
Figure 2.9 shows clearly that, in the CD45(-) fraction, no positive droplets are observed in 
samples derived from the blood of healthy volunteers, whereas numerous positive droplets 
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are detected when either A549s are spiked into the healthy donor sample, or the sample of 
a metastatic patient is analyzed.  
 
Figure 2.9: CTC detection in clinical samples. (A) Healthy volunteer sample. (B) Healthy 
volunteer sample with spiked tumor cells. (C) Sample from metastatic colorectal cancer patient. 
2.3. Conclusions 
This work provides the first proof-of-concept data that the cancer cell metabolism, and 
more specifically, the acidification of the extracellular microenvironment (so-called 
Warburg effect), can be used to identify and count rare tumor cells and CTCs. This method 
could overcome some limits of other technologies used for CTCs capture. Further work is 
needed to confirm these results and clarify how they can impact in clinical routine: positive 
events need to be isolated and characterized for cancer-specific proteins and genetic 
mutations, while clinical parameters as sensitivity, specificity, predictive values, must be 
established by dedicated clinical trials.  
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2.4. Experimental Section 
 Microfluidic circuit fabrication: 25 µm thick layer of SU8-2025 was spun on 
silicon wafer, baked, exposed through transparency mask, baked again and developed 
according to manufacturer instructions (MicroChem corp.). Sylgard 184 (PDMS) 
prepolymer and crosslinking agent (Dow Corning) were mixed at a mass ratio of 10:1 
(w/w); a mixture was poured onto a master, degassed and cured at 65°C for at least 2h. The 
replica was detached from master and reservoirs were bored using a blunt hypodermic 
needle.  A PDMS replica was washed in soapy water and ethanol, and blow dried with 
nitrogen.  A clean glass slide and a clean PDMS replica were treated with oxygen plasma 
and bonded. The device was silanized with 1% (Tridecafluoro-1,1,2,2-Tetrahydrooctyl)-1-
Trichlorosilane (Sigma-Aldrich) in FC-40 (3M), fluorinated oil, which was introduced into 
microfluidic channels (enough to completely wet whole microfluidic network) and then the 
device was kept at 95°C for at least 30 min. To fabricate a reservoir for an emulsified 
sample a brass cone (10 mm in dia. and 5 mm tall; ~130 µL volume) was placed directly 
on silicon wafer and replicated together with photolithographically defined features.   
Cells: Cell lines were a courtesy of Di Loreto lab, Hubrecht lab, and Colombatti lab. White 
blood cells (WBCs) were obtained by lysing whole blood with lysis solution (BD) 
according to manifacturer’s protocol. 
Droplet production: Monodisperse droplets are generated in chips with 20 µm wide T-
junction. Continuous phase: 2% (w/w) surfactant (Krytox–Jeffamine–Krytox A–B–A 
triblock copolymer)
1
 in HFE-7500 (3M) Dispersed phase: cell suspension in HBSS or 
Joklik’s modified EMEM, Optiprep 15%, pH-sensitive dye (4 µM. Flow rates are set such 
                                                 
1
 V.Chokkalingam, J.Tel, F.Wimmers, X.Liu, S.Semenov, J.Thiele, C.G.Figdor, W.T.S.Huck, Lab Chip 2013,13, 
4740-4744, doi: 10.1039/C3LC50945A 
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as continuous phase flow is at least 2 times higher than a flow rate of a dispersed phase; a 
typical flow rate for disperse phase was 300 µl/h and 600 µl/h for continuous phase. 
Lactate enzymatic assay: A three-channel architecture microfluidic circuit was used: one 
channel bringing the cell suspension (dispersed phase), one bringing the reagents of lactate 
assay (Cell Technology, Inc.) and one bringing continuous phase. Emulsification step was 
performed at 4°C to slow down cell metabolism to avoid lactate contamination of the 
whole solution by cancer cells. With this microfluidic device we could expose cells to the 
enzymes of the lactate assay only after encapsulation in the micro-droplets, to avoid 
unspecific activation prior the encapsulation. Images were taken after 15 min incubation at 
room temperature after emulsification.  
Widefield fluorescence imaging (lactate assay, pHRodo green experiments): An inverted 
epifluorescence microscope (Olympus IX81) was equipped with xCite 120Q lamp (Lumen 
Dynamics Group Inc.), resorufin and FITC filter sets (Semrock) and iXon 897 camera 
(Andor). An aliquot of processed sample was pipetted on a microscope glass slide and 
covered with a cover slip to prevent evaporation. 
High throughput detection with SNARF-5F. Setup: An inverted microscope (Olympus 
IX70) was used to analyze flowing droplets one by one.  A laser (488 Argon-ion Cyonics) 
beam was expanded (2x) and focused down with a cylindrical lens crossing orthogonally 
the microfluidic channel. The fluorescence signal of excited droplets was collected with a 
40x objective (Olympus LUCPlanFLN, 40x/0.60), split with dichroic filter (DLP555, 
Semrock) and detected through bandpass filters (579/34 630/38) by Photo Multiplier Tubes 
(PMTs) (H957-15, Hamamatsu). Signal went through a transimpedance amplifier with 
1V/uA gain and was detected by the acquisition system (National Instruments cRIO-9024, 
analog input module NI9223) with a 10 μsec scan rate. The acquisition system was driven 
by LABView in house written software. The software detects all data-points of a droplet 
over a set threshold and computes in real time averaged values; it also provides trigger 
pulse for image capture on a camera. Liquids were pumped using neMESYS (Cetoni) 
syringe pumps. 
A549 quantitation. Cultured cells were washed with PBS, trypsinized and transferred into 
medium (typical concentration 500,000 to 1000,000 cell/mL). Cells were spun down and 
resuspended in Joklik’s modified EMEM (pH 7.4). If lower concentration of A549s was 
required, cell suspension was diluted to ~ 1000 cell/mL in Joklik’s modified EMEM. 100 
µL of sample solution was obtained by mixing cell suspension, SNARF-5F stock (conc. 1 
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mM) and in Joklik’s modified EMEM. Fraction of obtained solution was used to verify 
A549 concentration in counting chamber. 1 to 2M cell/ml suspension of WBC in Joklik’s 
modified EMEM was used to prepare samples of A549 with WBCs. Samples were 
emulsified at flowrate of 300 µL/h (600 µL/h for oil), collected in cone reservoir and 
incubated for 20 minutes. Droplets were reinjected from cone device directly into a readout 
device (50 to 100 µL/h for droplets; 300 to 500 µL/h for spacer oil). Detected cancerous 
cells were verified with images acquired for droplets with reduced pH. 
CD45 immunomagnetic depletion: We followed manifacturer’s protocol for CD45+ 
depletion using Miltenyi human CD45 Microbeads, MidiMACS™ Separator, MultiStand 
and LD Column. 
Patient protocol: 1-2mL of whole blood from metastatic cancer patients was lysed, 
depleted of CD45+ fraction, CD45-Alexa488 stained and resuspended in incubation buffer, 
for a final volume of 50uL 15% Optiprep. 
Patient spike protocol: A549 cells were spiked into 1-2mL of whole blood from healthy 
donor and “patient protocol” was followed. 
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3. CHAPTER 3  
Microfluidic synthesis of Peptide-functionalized microgels 
for in serum selective protein detection 
Abstract. Polymeric microparticles represent a robustly platform for detection of 
clinically relevant analytes in biological samples; they can be functionalized with multiple 
types of biologics entities, enhancing their applications as a new class of colloid materials. 
Microfluidics offers a versatile platform for synthesis of monodisperse and engineered 
microparticles. Microfluidic synthesis of novel polymeric microparticles endowed with 
specific peptide due to its superior specificity for target binding in complex media is 
presented. A peptide sequence was efficiently encapsulated into the polymeric network and 
protein binding occurred with high affinity (KD 0.1-0.4 µM). Fluidic dynamics simulation 
was performed to optimize the production conditions to obtain monodisperse and stable 
functionalized microgels. The results demonstrate the easy and fast realization, in a single 
step, of functionalized monodisperse microgels using droplet-microfluidic technique, and 
how the inclusion of the peptide within polymeric network improve both the affinity and 
the specificity of protein capture. 
 
This work has been submitted for publication: G.Celetti; C. Di Natale; F. Causa; P.A. Netti; “Functionalized 
poly(ethylene glycol) diacrylate microgels by microfluidics: in situ peptide encapsulation for in serum 
selective protein detection”.  
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3.1. Introduction 
Recently, hydrogels-based technologies have been developed for a wide range of 
biotechnology applications including diagnostic
1-3
, drug delivery
4,5
 and tissue 
engineering
6,7
. Because of their biocompatibility and high tunability hydrogels represent 
ideal candidates for biosensing applications. Their microstructure and interfacial 
proprieties can also be rendered responsive to various stimuli through chemical and 
physical cues, resulting in “smart” materials which can respond to their local environment1. 
In particular, hydrogels can be engineer with different biological entities such as nucleic 
acids or peptides for capture and detection of proteins, DNA, mRNA and microRNA
8
. 
Hydrogels are typically prepared and processed as bulk materials such as monolithic 
structures or supported films. However, emerging applications for delivery and transport 
purposes in microscopic environments require miniaturization and tailoring of hydrogel 
architecture at increasingly small length scales. This requirement has prompted 
development of new methods for synthesis of hydrogel microparticles, as know as 
“microgels”1. Hydrogel microparticles have been suggested as diagnostic tools for the 
rapid multiplexed screening of biomolecules, due to their advantages in detection and 
quantification
9-11
. Compared to traditional planar arrays, particle-based arrays offer easier 
probe modification, more efficient mixing, and higher reproducibility
12
. However, 
appropriate methods to functionalize of large microparticles have not yet been developed
13
.  
Synthesis of hydrogel microparticles in microfluidics represents one of the most promising 
production methods; two examples are droplet microﬂuidics14-16 and flow lithography14. In 
particular, droplet microﬂuidics facilitates fabrication of spherical microparticles (i.e., 
microspheres) or microparticles with complex chemical compositions and potentially 
enables high throughput synthesis
17
. Prior reports have demonstrated the ability of 
microﬂuidic-based platforms to synthesize, functionalize and encode microparticles with 
multiple bioactive agents
14,18,19
, overcoming the conventional emulsion polymerization 
methods
20
.  
Due to its biocompatibility and low-biofouling properties poly(ethylene glycol) (PEG) has 
been widely used for hydrogels particles-based assays. Various approaches have explored 
PEG’s utility as biosensor platform including direct physical entrapment21 or covalently 
linking the biomolecules  to the polymer network
22
.  
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Most of validated detection strategies use monoclonal antibodies as target recognition 
moieties, but the use of these large macromolecules has several limitations, including poor 
stability and high production costs
23,24
. In contrast, small molecules like peptides can be 
prepared synthetically and they mimic the antibody binding site by using only a small 
cluster of residues, even though with lower affinity and specificity toward biomolecule 
target
25
. Hydrogel networks endowed with bioactive peptides have been already reported 
for applications such as tissue engineering, where short peptide sequences were 
demonstrated to elicit specific cell functions or change the materials network upon specific 
cell responses
26
. However, the capability of hydrogel microparticles, functionalized with 
small molecules in a single step, to increase the affinity and the specificity of a protein 
capture has not yet been explored.  
Here, droplet microfluidics is used for one step synthesis of monodisperse and stable 
micrometer poly(ethylene glycol) diacrylate (PEGDA) hydrogels. A reactive and labeled 
peptide sequence was incorporated in the microgels to create a functional microparticles 
for selective protein detection in complex fluid (Figure 3.1), eliminating the need for 
costly and time-consuming labeling steps. Computational fluidic dynamics simulation 
(CFD) was used to optimize the design of the device investigating the parameters that 
influence droplet formation. Protein detection in buffer and in complex biological medium 
was demonstrated by confocal technique. This approach promises to be useful for 
producing a novel, efficient and sensitive polymeric microparticles to detect bio-molecular 
targets with higher affinity in complex medium. 
 
Figure 3.1: Schematic representation of Strep-tag II-microparticles synthesis able to detect 
Streptavidin protein in human serum. Such approach includes: phase modelling; microfluidic 
fabrication and validation; microgel synthesis; and assay validation for selective protein detection. 
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3.2. Results and discussion 
3.2.1.  Microfluidic design 
Microfluidic design (Figure 3.2), was optimized to obtain monodisperse and stable 
functional microgels in order to create a tool-system for biosensing.  
 
Figure 3.2: Schematic representation of FFD for Strep-tag II-microparticles synthesis. 
Droplet formation process is affected by several physical parameters such as flow rates, 
viscosity of the fluids, dimensions of the geometry, Capillary number (Ca) and surface 
tension
15
; therefore, the design of optimal microfluidic device for the production of 
monodisperse and stable emulsion relies on controlling such parameters.  
In the first set of simulations the influence of geometry and Ca on 
droplet production was investigated. Firstly, the dimensions of 
the device junction were changed; in particular, different widths 
and lengths were modeled. Based on the simulation results, 50 × 
35 × 50 (width × depth × length) were the chosen dimensions of 
the junction in the region of droplet formation. 
Droplet formation is driven by the competition between the 
viscous stress and the surface tension of two immiscible fluids, 
this occurs at a critical Capillary number
27
. For this, the influence 
of Ca on emulsion stability was investigated, maintaining 
geometry device constant. Ca can be modified by varying the 
flow rate of the continuous phase (Qoil). Simulation results 
shows three different flow patterns after the junction: elongation 
flow pattern, stable emulsions and unstable emulsions (Figure 3.3 
A, B, C). It is difficult generate stable emulsion at high flow 
Figure 3.3: Three distinct 
regions were observed: a) 
elongation flow of thread, b) 
stable droplets, (c) unstable 
droplet formation 
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rates of prepolymer solution (Qp > 5 µl/min, in this case); in fact, W/O emulsion could not  
separate uniformly from the junction due to the unstable hydrodynamic pressure of 
PEGDA prepolymer phase. When the value of Ca is in a limited range 0.005 ~ 0.055, the 
prepolymer phase breaks into a stable emulsion (regime of stable emulsions Figure 3.3B). 
Choi et al. also investigated flow patterns to obtain stable polymeric droplets
28
. 
Precise control of particle size and monodispersity is critical for many applications of 
microgels; microfluidic platform provides control over a wide range of sizes. For this 
reason, in the second set of simulations the influence of Qoil on the droplet size was 
investigated, while Qp was kept constant. Once the dimensions of the device have been 
fixed, microgels with a wide range of sizes, ranging from 10 to 90 µm, were produced. 
Droplets diameters were calculated during simulation analysis. In particular, a droplet size 
was determined by the flow rates of the two phases and the ratio between these flow rates, 
as proposed by Collins et al. Maintaining the ratio of the two flow rates constant, droplets 
size decreases as Qoil increases.  
In order to stabilize droplets against uncontrolled coalescence, the use of surfactant is 
necessary. These amphiphilic molecules are commonly used to stabilize the droplet 
interface and to prevent coalescence of droplets
16
. The interfacial tension is strongly 
dependent on the surfactant’s local surface coverage, but, in turn, it affects significantly 
droplet size and stability during emulsification
27
. The interfacial tension between the two 
phases is influenced by the viscousities of the fluids. Figure 3.4 show the correlation 
between the polymer's concentration in the disperse phase and its viscosity. Increasing the 
amount of the polymer, the viscosity of the disperse phase increases resulting in a loss of 
droplets' stability. 
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Figure 3.4: measures of PEGDA viscosity solution at 20%, 40%, 60% wt. through 50 mm flat-
plate geometry by rheometer. The viscosity increase when the concentration of PEGDA in water 
solution (disperse phase) increase.  
If the prepolymer concentration is lower than 20 wt %,  its solution can be used to form 
droplets, but required UV curing is  long and these droplets deform and damage easily
8
. In 
contrast, a solution with PEGDA concentration higher than 60 wt % can be cured by UV 
light in less time; but it is difficult to control the stability of the droplets because of their 
high viscosity
29
. A dispersed phase at 20 wt.% of PEGDA was chosen, setting the length of 
the circuit in the device at 10 cm for droplets polymerization directly in flow using the UV 
lamp of the microscope. 
3.2.2. PEGDA peptide-microgels synthesis and characterization 
Here microfluidic synthesis of biodegradable PEGDA peptide-microgels for diagnostic 
applications is reported. The encapsulated peptide (Strep-tagII) contains sequence of eight 
amino acid (H2N–WSHPQFEK–COOH) selected from a random peptide library as an 
artificial ligand for streptavidin protein
30
. It is usually used for efficient protein purification 
in a single step and it is also important in the study of metallo-proteins
31
. The peptide was 
labeled with fluorophor for verification of its encapsulation. Microgels formation is shown 
in Figure 3.5 and described in Experimental Section. Briefly, the pre-polymer solution 
containing Strep-tagII-FITC peptide was injected through the central channel of the 
microfluidic device, as disperse phase, and oil solution with surfactant through its two 
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opposite side channels, as continuous phase. Disperse phase was sheared into 
monodisperse droplets by continuous phase.  
Microfluidic set up allows robust and rapid synthesis of functional and uniform polymeric 
microparticles in a single step, overcoming the limits of the conventional suspension 
polymerization methods. Strep-tagII-microgels are monodisperse in size with a coefficient 
of polydispersity (PDI) < 0.003 and the homogeneity of the peptide inside the microgels 
(≈1.31 pg of peptide in each microgel) was confirmed by confocal image (Figure 3.6). 
Uniform particle size and homogeneous peptide labeling make this approach promising for 
selective protein detection. 
 
 
Figure 3.5: PEGDA-peptide microgel (20% PEGDA, 0.1% Darcour, 0.5 mg/mL peptide). (A) 
Strep-tagII microgels synthesis by microfluidic device. (B)Size distribution of PEGDA-peptide 
microgels. (C) Fluorescent image of Strep-tagII-FITC encapsulation. (D)Phase contrast image of 
microgels. Scale bars are 100 µm. 
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Figure 3.6: image 3D of PEGDA Strep-Tag-II,confirm the homogeneity of the peptide inside 
microgels. 
Despite the addition of biologic entities may lead to a slight increase in the deviation of 
diameter, the resulting microgels remained largely uniform, thereby demonstrating the 
ability of our approach to encapsulate biomolecules in polymeric microparticles.  
PEGDA has been chosen for its advantages over other polymers and its specific 
proprieties, such as good biocompatibility, non-toxicity, low immunogenicity in vivo, and 
resistance to protein adsorption. Moreover, polyethylene glycol (PEG) hydrogels are 
widely used in biomedical fields such as drug delivery and tissue engineering
32
 
Finally, to verify the secondary structure of the peptide in solution and inside microgels, 
circular dichroism (CD) was performed. CD spectra of peptide registered in aqueous buffer 
solution (Figure 3.7A) revealed a random coil content due to the absence of Cotton bands 
at 205, 222 nm that are typical of helix conformations. As showed in figure 3.7A the 
addition of different TFE concentrations results in an increase of helical content, in 
particular at 60% of TFE peptide spectrum shows a presence of little Cotton bands at 205 
and 222 nm. The same experiments were carried out for peptide incorporated into the 
microgels. CD data confirmed that Strep-tagII peptide retains its structure (random-coil as 
it expect for small peptides) after its encapsulation, as previously reported for other 
peptides
33
. Figure 3.7B shows CD spectrum of Step-tagII peptide and Strep-TagII 
microgels. In order to analyze the structural behavior of the peptide encapsulated into the 
microgels, CD spectrum at 60% of TFE was recorded. In contrast of peptide spectrum at 
60% of TFE, peptide encapsulated didn’t change its conformation even with high TFE 
content, showing only a slight band at 220nm. Figure 3.7C and D show CD data of Strep-
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tagII-microgels recorded at 0 and 60% of TFE and peptide spectrum in solution and 
incorporated inside microgels at the same TFE concentration. 
 
Figure 3.7: CD analysis of Strep-tagII peptide and Strep-tagII peptide-microgels, in phosphate 
buffer 10 mM pH 7. Overlay of Strep-tagII peptide CD spectra recorded (A) with increasing 
amounts of TFE (from 0 to 60%), Overlay of StreptagII-peptide and StreptagII-microgels CD 
spectra in buffer solution (B), Overlay of StrepTagII microgels CD spectra recorded (C) with 0% 
and 60% of TFE and Overlay of StrepTagII peptide and microgels recorded (D) with 60% of TFE. 
Importantly, our strategies is relatively simple and robust, and encapsulated molecules 
retain their structure during microgels processing. Moreover, we demonstrate that CFS 
allow a robust control over microgels synthesis, avoiding fabrications of many different 
microfluidic devices. 
3.2.3. Protein-binding analysis in PBS and human serum 
One motivation for using peptides in polymeric networks for protein detection is to employ 
them to have a selective protein detection in complex mixtures
34
. Protein-binding peptide 
is described in more details in Experimental Section. Different concentrations of 
Streptavidin protein (labeled with Atto-425), ranging from 0.16 µM to 1.6 µM, were used 
in the experiment. Figure 3.8B shows Streptavidin-Atto-425 fluorescence on Strep-tagII-
microgels in PBS. The selective binding of protein was demonstrated using the same 
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protocol for Control-microgels labeled with rhodamine B (Figure 3.8E). Atto-425 
fluorescence signal occurred only on Strep-tagII-microgels and its intensity increased with 
increasing protein concentration (Figure 3.8L) in sample, giving a reasonably specific 
binding signal.  
Most important is to test binding in complex mixtures where other interfering proteins are 
in abundance. We evaluated the accuracy of our system directly in biological environment. 
Fluorescence image (Figure 3.8H) confirms protein-binding peptide and the accuracy of 
the microgel-based assay also in complex matrix. 
 
Figure 3.8: Fluorescence detection of specific and unspecific binding both in PBS and in human 
serum. Single component detection: (A) strep-tagII-microgels (green) and (B) Streptavidin binding 
microgels (blue); (C) Overlay image. The single component images demonstrate that there is no 
occurrence of overlapping signals. (D) PEGDA microgels labeled with Rhodamine B (red) as a 
control of unspecific signal; (E) fluorescence image of streptavidin on control microgels; (F) 
overlay channel; (G) Strep-tagII-microgels (green) and (H) Streptavidin binding microgels (blue) in 
human serum; (I) Overlay image for specific protein-binding peptide in human serum; (L) Bioassay 
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system efficiency of microgels-bounding; (M) Performance of bioassay system for protein 
detection in PBS and in human serum. The binding event is detected by measuring the fluorescence 
intensity of Atto-425 conjugated Streptavidin directly on 50 microgel particles. Statistical 
difference between Strep tag II-microgels and control microgels *p<0.05 (mean±SD n=2) in PBS 
and *p>0.05 (mean±SD n=2) in human serum. 
It is evident that Streptavidin-Atto-425 recognition is specific and dose-response (Figure 
3.9A), with an estimated KD of 0.40±0.11 µM, which demonstrate a good affinity toward 
Streptavidin protein. As reported the maximum constant affinity between such peptide and 
protein is about 70 µM
35,36
, therefore microgel is able to improve the sensitivity and 
specificity of protein detection. We observed that there was no obvious change of 
fluorescent intensity when the concentration of Streptavidin-Atto-425 was higher than 1.6 
µM. Thus the saturation point of Streptavidin-Atto-425 was higher than 1.6 µM in PBS.  
Moreover Figure 3.9B shows that the fluorescence intensity of the Streptavidin-Atto-425 
is dose-responsive and specific in serum as well, with a KD of 0.12±0.047 µM
37
. Such 
performance is ascribable to the capability of the polymeric network to offer antifouling 
properties, thus improving the specificity of the capture.  
 
Figure 3.9: Strep-tagII-microgels-protein binding confocal results. (A) the Streptavidin-ATTO-425 
recognition (red curve) is specific, unlike Control-microgels (black curve) (mean±SD n=2). (B) 
Comparison of confocal binding by non linear fitting in buffer (red curve) and in serum (blue 
curve). 
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We synthesized functional microgels for selective protein detection both in PBS and in 
complex fluid, using droplet-microfluidics. This method is relative simple, rapid and 
support the use of microfluidic device as a manufacturing platform for biosensing. 
We believe that the reported system can be broadly applicable for rapid synthesis of 
microgels for different application like food contaminants detection, using different small 
molecules. 
3.3.  Conclusions 
Here we report droplet-microfluidics for the easy and rapid synthesis of biodegradable 
PEGDA peptide-microgels for selective biomolecules capture in complex medium, unlike 
conventional techniques. Based on numerical simulations, we fabricate microfluidic device 
to produce stable and monodisperse microgels. Uniform distribution of the specific peptide 
within the microgel was achieved and the efficiency of peptide-to–protein binding both in 
PBS and human serum was confirmed. These functional microparticles allows the 
enhancement of binding affinity and the specificity in complex media. 
Our system is simple and flexible towards the detection of different molecules, does not 
require preliminary treatments of the sample and allows for the specific detection in 
complex fluid because of its antifouling properties. The control of physical and chemical 
properties of microgels through droplet microfluidics and the flexibility to encapsulate 
different molecules make our method useful for any direct bio-detection in complex fluids. 
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3.4.  Experimental Section 
General Materials and Method. Poly(ethylene glycol) diacrylate (PEGDA, 700 MW), the 
non polar solvent light mineral oil and the nonionic detergent sorbitan monooleate (Span 
80) were purchased from Sigma Aldrich. Crosslinking reagent Darocur 1173 was 
purchased from Ciba. Reagents for peptide synthesis (Fmoc-protected amino acids, resins, 
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activation, and deprotection reagents) were purchased from Iris Biotech GmbH 
(Waldershofer Str. 49-51 95615 Marktredwitz, Deutschland) and InBios (Naples, Italy). 
Solvents for peptide synthesis and HPLC analyses and Streptavidin ATTO-425 were 
purchased from Sigma-Aldrich; reversed phase columns for peptide analysis and the LC–
MS system were supplied respectively from Agilent Technologies and Waters (Milan, 
Italy). Pooled human serum from healthy donors was supplied by Lonza (Life Technology 
Ltd, Paisley, UK). All chemicals were used as received. 
Microfluidic device fabrication. Microfluidic device consists of two inlets for the 
continuous and disperse phase, a narrow orifice in which the main channel and the two 
opposite channels converge, and a serpentine in which droplets were polymerized. The 
dimensions of the the microchannel dimensions in the region of droplet formation is  50 × 
35 × 50 (width × depth × length); the serpentine is 10 cm long. The microfluidic device 
was fabricated by combining the conventional photolithographic and soft-lithographic 
techniques. Briefly, negative photoresist (Mr-DWL 40 phtoresist, Microresist technology) 
was spun onto a silicon wafer at 2000 rpm for 30 s to make a 35 µm thick layer of 
photoresist. Then, the photoresist was baked and subsequently exposed using DWL 66 Fs 
LASER technology system (Heidelberg instruments). After the exposed sample had been 
post-baked and developed, the microfluidic flow focusing device master was prepared. The 
surface of the device mold was treated with tridecaﬂuoro-1,1,2,2-tetrahydrooctyl-1-
trichlorosilane to facilitate the peeling off of the polydimethyl-siloxane (PDMS, Sylgard 
184, Dow Corning) replica. PDMS (10:1 polymer to curing agent) was poured on the 
patterned silicon wafer containing negative-channels. The PDMS-based microfluidic 
device was peeled off from the wafer and bonded on a glass slide with oxygen plasma 
treatment.  
Computational Fluid Dinamic simulation. To optimize the design of the device, 
computational fluid dynamics simulations were performed using COMSOL Multiphysics 
4.2b software. During the simulation, all geometries were created two-dimensional based 
on the dimensions of the designed microfluidic device. A two-dimensional model was 
chosen to reduce complexity and computation time. The momentum and mass balances 
were modeled by Navier-Stokes equations and the level set method (LSM) was used to 
model the two phases. The principle on which LSM is based is the assignment of a so-
called level set function Φ(x, t) to the space occupied by an interface, where x denotes the 
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co-ordinates of a point within that space at a time t. The function is initialized at time t0, 
and then a numerical scheme is used to approximate the value of Φ(x, t) over small time 
increments, thus enabling the propagation of the interface to be tracked in time. The 
interface is represented by the zero contour of the level set function Φ. Φ > 0 on one side 
of the interface and Φ < 0 on the other. The level set function is chosen such that the 
position of the water–oil interface is described by the 0.5 contour of the level set function 
Φ and for Φ > 0.5 the break off occurs and the droplet is formed. Channel geometries were 
meshed using the free meshing tool and the channel walls were specified as wetted walls 
with a constant contact angle, measured experimentally using the instrument Contact 
Angle CAM 200. The interfacial tension between the continuous phase and the prepolymer 
solution was changed to investigate the influence of the surface tension (γ) on the droplet 
sizes. γ was measured by pendant drop CAM 200. The viscosity of the two fluids was 
measured with 50 mm flat-plate geometry by rheometer.  
Synthesis of Strep-TagII peptide. Strep-tagII-peptide ((WSHPQFEKD(OAll))) synthesis 
was performed on a fully automated multichannel peptide synthesizer Biotage® Syro 
Wave™. Preparative RP-HPLC was carried out on a Waters 2535 Quaternary Gradient 
Module, equipped with a 2489 UV/Visible detector and with an X-Bridge
TM
 BEH300 
preparative 10× 100 mm C18, 5μm column. LC–MS analyses were carried out on an 
Agilent 6530 Accurate-Mass Q-TOF LC/MS spectrometer. Zorbax RRHD Eclipse Plus 
C18 2.1 x 50 mm, 1.8 µm columns were used for the analyses. The Strep-tagII-peptide was 
synthesized in the acetylated/amidate version, employing the solid phase method on a 
50 μmol scale following standard Fmoc strategies. Rink-amide resin (substitution 
0.45 mmol/g) was used as solid support. Activation of amino acids was achieved using 
HBTU/HOBt/DIPEA (1:1:2). All couplings were performed for 15 min and deprotections 
for 10 min. To monitor peptide entrapment, Lysine side chain amine fluorescein labeling 
was achieved by on-resin treatment with fluorescein isothiocyanate (FITC) after removing 
methyltrityl (Mtt) protecting group using 1% TFA in DCM for 30 min. Peptide was then 
removed from the resin, by treatment with a TFA/TIS/H2O (95:2.5:2.5, v/v/v) mixture for 
90 min at room temperature; then, crude peptide was precipitated in cold ether, dissolved 
in a water/acetonitrile (1:1, v/v) mixture, and lyophilized. Product was purified by RP-
HPLC applying a linear gradient of 0.1% TFA CH3CN in 0.1% TFA water from 5% to 
70% over 30 min using an X-Bridge
TM
 BEH300 preparative 10× 100 mm C18, 5μm 
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column at a flow rate of 10 mL/min. Peptide purity (95%) and identity (1488 amu) was 
confirmed by LC–MS (data not shown). Purified peptide was lyophilized and stored at 
−20 °C until use. 
Synthesis of functional microgels. Microgels were synthesized using light mineral oil 
containing nonionic surfactant Span 80 (3 wt%) as a continuous phase and poly(ethylene 
glycol)diacrylate (PEGDA) (20 wt%) with photoinitiator (0.1 wt%) and Strep-tagII-FITC 
(0.5 mg/mL) as a disperse phase. Droplets were formed injecting prepolymer solution, 
disperse phase, through the central channel and oil solution, continuous phase, through two 
opposite side channels. The uniform PEGDA-peptide droplets were crosslinked in flow to 
form monodisperse microgels. To photopolymerize droplets DAPI microscopy filter (9.8 
mW, λ=360 nm) was used, focusing the UV light on the serpentine and regulating the 
diaphragm aperture of the microscope, for 15s. After photopolymerization, microgels were 
collected in an eppendorf and washed three times with a solution of ethanol (35 v/v%) and 
acetone (10 v/v%) to remove the oil. After washing, microgels containing Strep-tagII-FITC 
were analyzed by confocal microscopy. Polyethylene tubes were connected to the inlets 
and outlets and the solutions were injected using high-precision syringe pumps (neMesys-
low pressure) to ensure a reproducible, stable flow. This system was mounted on an 
inverted microscope (IX 71 Olympus) and the droplets formation was visualized using a 
4× objective and recorded with a CCD camera Imperx IGV-B0620M.  
Protocol of peptide encapsulation and protein-binding analysis. Peptide was encapsulated 
adding Strep-tagII-FITC (0.5 mg/mL) to the disperse phase prior to microgel synthesis. 
Fluorescent microgels without peptide, used as negative control, were obtained dissolved 
0.1 mg of Rhodamine B in 10 mL of water solution. Binding experiments were performed 
incubating Strep-tagII-microgels and microgels without peptide (Control-microgels) with 
Streptavidin-Atto-425 (peptide/protein ratio 5/1) in PBS (pH 7.4) and human serum from 
healthy donors (final volume 200 mL) at room temperature for 2 h. After incubation Strep-
tagII-microgels and Control-microgels were centrifuged for 5 min at 10000 rpm and the 
supernatant was measured by fluorescence spectroscopy (λ exc 436 – λ em484) using a 
Perkin Elmer 2300 Enspire Plate Reader. 
To demonstrate the ability of our system to detect specific protein, 100 µL of Strep-tagII-
microgels were suspended in 1 mL of PBS and different concentrations of Streptavidin 
protein, ranging from 0.16 µM to 1.6 µM, were added and these solutions were incubated 
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for 2 h. After the incubation, microgels were washed three times and their fluorescence 
was analyzed. The same protocol was used for microgels without peptide, as a negative 
control, and for Strep-TagII-microgels in serum analysis as well. 
Confocal Microscopy. Microgels images, before binding, were collected with Leica 
confocal microscope SP5 (Leica Microsystems), provided with an HCX IRAPO L 
25.0×/0.95 WATER objective and an Argon laser (488 nm as selected wavelength) as 
excitation sources for FITC-peptide. Detection occurred at the 500-530 nm band. Images 
have been acquired with a resolution of 1024 × 1024 pixels, zoom 1, 2.33 A.U. pinhole. 
All our experiments were performed at room temperature.  
Fluorescence analysis of protein-binding was performed by Zeiss LSM700 confocal 
microscope, using 20× dry objective. Two-channel fluorescence images were acquired, 
simultaneously, using multitrack mode. 480 nm and a 405 nm DAPI solid state lasers as 
excitation sources were used for peptide-FITC and Streptavidin-Atto-425-protein 435, 
respectively. Fluorescence was detected at 500-530 nm and 410-450 nm bands, 
respectively.  
Circular Dichroism analysis. CD spectra were recorded using a JascoJ-1500 
spectropolarimeter in a 1.0 cm quartz cell at room temperature. The spectra were recorded 
from 300 to 190 nm, with a band width of 1 nm, a time constant of 16 s, and a scan rate of 
10 nm/min. Blank samples were subtracted from all recorded spectra. 
Statistical analysis. The results of confocal experiments were analyzed by software 
GraphPad Prism version 5.04 and experimental data were expressed as mean ± standard 
deviation. One-tailed analysis of variance with an Unpaired t-Test was performed to 
compare all experimental groups and to determine statistical significance of p < 0.05. The 
evaluation of KD was calculated by a non-linear fitting approach using GraphPad Prism 
version 5.04 software. 
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4. CHAPTER 4  
 
Label-free method for aflatoxin detection: microfluidic 
microgels functionalized with two novel peptides 
Abstract. A novel method using droplet microfluidics for aflatoxin M1 (AFM1) detection is 
presented. AFM1 is the most toxic, carcinogenic, teratogenic and mutagenic class of aflatoxins 
(AFs) and is present in a wide range of food and feed commodities, such as milk and dairy 
products. In the last ten to twenty years the presence of AFM1 in such products has been an 
important issue world, especially for developing countries. In this work poly(ethylene glycol) 
dyacrilate (PEGDA) functionalized microparticles, as a novel tool for sensitive and label-free 
detection of aflatoxin M1 (AFM1), were synthesized. PEGDA microparticles were produced 
and functionalized through droplet microfluidic device. Two novel peptides, synthesized for 
specific aflatoxin detection, were encapsulated into the microgels directly in flow. AFM1 
detection was achieved measuring its innate fluorescence. The fluorescent signal increased 
with the increment of AFM1 concentration in sample. The detection limit of this technique for 
AFM1 was estimated to be 1.64 ng/Kg, with a dynamic detection range between 3.28 ng/Kg 
and 656 ng/Kg, which meets present legislative limits of 50 ng/Kg. Therefore, the developed 
systems, using microfluidics, provides a promising approach for rapid screening of food 
contaminates because it is simple, sensitive, specific, without the need of multiple separation 
steps, overcoming the limits of the traditional AFM1 capture methods, which are expensive 
and time consuming. 
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4.1. Introduction 
AFM1, a hydroxylated metabolite of aﬂatoxin B1, is often found in milk from animals fed 
with aﬂatoxin B1-contaminated feeds (Figure 4.1)1,2. AFM1 can be also found in a variety of 
dairy products such as cheese, yogurt, and infant formula due to its resistance to heat 
treatment
3
. AFM1 is the most toxic, carcinogenic, teratogenic and mutagenic class of 
aflatoxins
4
. Therefore, the contamination of foods by AFM1 could pose a serious risk to 
public health, especially to milk consumers.  
 
Figure 4.1: schematic representation of AFM1 
The EU limits the total AF levels to no more than 0.05 µg/Kg in milk (the United States Food 
and Drug Administration established action levels for AF concentration of 0.5 µg/Kg, 
however the Codex Alimentarius set 0.05 µg/Kg as the regulatory limit)
3
. This has prompted 
the adoption of regulatory limits in several countries, which, in turn, requires the development 
of validated official analytical methods for rapid and cost-effective screening of AFM1 on a 
large scale. 
Currently, several qualitative and quantitative methods have been developed to detect AFM in 
milk and in dairy products
5-9
. Among them, thin layer chromatography and immune 
chromatographic assay are the most commonly used methods for rapid qualitative detection 
and semiquantiﬁcation of aﬂatoxins. For examples, the quantification of AFM is usually 
conducted by high performance liquid chromatography (HPLC) and enzyme linked 
immunosorbent assay (ELISA)
10,11
. The HPLC fluorimetric detection method can quantify 
AFM with high accuracy and very low detection limits, but it requires complex and laborious 
samples pretreatments, such as defatting of milk and subsequent extraction of AFM by 
methanol or immunoaﬃnity columns12,13 . Moreover the chromatographic methods require 
expensive instrumentatio and skilled operators
1314
, thus limiting their application, especially 
in developing countries. In addition, several biosensors have also been developed to analyze 
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the AFM, including electrochemical immunochip sensor and DNA-based electrochemical 
membrane
15-17
. 
The emerging research field of microfluidics provides exciting new possibilities for advanced 
development of new analytical methods
18-20
. Droplet microfluidic technologies enable to 
develop a novel biosensor with high control and can tailor the properties of biosensors in a 
very simple manner to meet the needs of specific applications. However, droplet microfluidics 
is used only for biomedical and chemical research; limited work has been done for detection 
of food contaminates using these technologies.  
Recently, biorecognition elements (such as enzymes, peptides and antibodies) are used for 
detection of specific anilities. Several group have synthesized antibodies for aflatoxin 
recognition, with high sensitivity
6,21
. The use of these large macromolecules has several 
limitations, including poor stability and high production costs
22
. In contrast, small molecules 
like peptides can be prepared synthetically and mimic the antibody binding site by using only 
a small cluster of residues, even though the affinity and specificity toward biomolecules target 
result to be lower if compared with antibodies
23
. Based on these consideration, 64 peptides 
were screened and the sequences which showed the best affinity to aflatoxin were 
synthesized. 
Poly(ethylene glycol) (PEG) is commonly used in biotechnological applications due to its 
low-fouling and biocompatibility properties. PEG is used to prevent non-specific binding of 
protein on sensing surface and it is relative inexpensive
24
. These properties make PEG an 
attractive material for biosensors intended to work in complex samples without purification, 
overcoming the complex and laborious steps of samples purification that is typical in the 
conventional methods. Various approaches have explored PEG’s utility as biosensor 
platform
25
, but we believe that its use in recognition of food contaminants has not yet been 
developed.  
We report a simple, low-cost and label free method for aflatoxin M1 detection based on 
microfluidic poly(ethylene glycol) diacrylate (PEGDA) microparticles functionalized with 
two novel peptides. 64 anti-AFM sequences were screened by Surface Plasmon Resonance 
(SPR) technique, and the sequences showing best binding affinity (KD= 180±0.5 µM and 
KD=172±0.4 µM) were chose for our system.  AFM1 capture beads were made from PEGDA 
microparticles functionalized with the selected peptide moieties. All tests have been 
performed using AFM1 conjugated with BSA, becuase the BSA-conjugation make the toxin 
less harmfull and easier to manage. AFM1-BSA-binding peptides occurred with high affinity 
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(KD 3.66-6.57 pM, respectively for the two sequences) and detection was demonstrated by 
fluorescent technique. The results demonstrate that the proposed system system is able to 
detect levels of AFM1-BSA in according with the current legislative requirements of 50 
ng/Kg. 
The method developed for Streptavidin recognition in complex matrix can be used for 
aflatoxins detection providing a promising approach for the screening of food contaminates 
and small molecules.  
4.2. Results and discussions 
4.2.1. Peptides sequences characterization  
The first step was the selection of the peptide sequences that has showed the best affinity with 
AFM1. To this end, a preliminary Molecular Docking experiment for studying affinity 
between AFM1 and several peptides was performed using Cdocker, an algorithm of 
Discovery Studios software. Molecular Docking is usually used for the prediction of the 
preferred orientation of one molecule to a second one when bound to each other to form a 
stable complex
26
. Knowledge of the preferred orientation in turn may be used to predict the 
strength of association or binding affinity between the molecules using, that in our case are 
been peptide and AFM1. This part of work is been made in a parallel PhD work, and it is not 
the object of this one. Briefly, here it is reported a description of the peptides which were 
chosen for the work.  
After Molecular Docking experiment, 64 peptides were synthesized through combinatorial 
chemistry, for its rapidity and low cost unlike conventional synthetic way of handling one 
molecule at time
27
. Eight amino acids alanine, arginine, aspartic acid, asparagine, threonine, 
proline, isoleucine and tryptophan (A,R,D,N,T,P,I,W  respectively) were chosen as building 
blocks, because of their chemical properties (i.e. solubility, different functional groups), their 
easy availability and their low cost. The amino acids chosen for preparing a library of 
sufficient size have functional groups in their lateral chains that could not react under our 
synthesis conditions. To avoid synthetic problems, the composition of the library was 
simplified by neglecting other amino acids (see experimental section for more details). In this 
way a known linear amino acid sequence was easily obtained. To estimate the biospecific 
interaction peptides-aflatoxin a commercially available instrument (SensiQ) was used, which 
employs the principle of Surface Plasmonic Resonance (SPR). Refractive index changes 
associated with peptide binding to the aflatoxin-BSA conjugate are detected and quantified 
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(as response units (RU)) by the instrument as a sensorgram
28
. In our experiments AFM1-BSA 
conjugated as ligand was immobilized on the chip COOH5, achieving 400 RU immobilization 
level (approximately 1RU is about equal to 1pg/mm
2
 of ligand immobilized). Direct binding 
of each peptide with AFM1 were performed by injecting different concentration of peptides 
(see Experimental Section). Figure 4.2 shows the binding of the best two sequences in real-
time as a plot of time (seconds) versus response signal (RU) (sensorgrams). The dissociation 
rates (KD), which define the kinetics and affinities of the interaction, was calculated from 
these sensorgrams
28
. 
 
 
Figure 4.2: Sensorgram of response unit versus time illustrating the binding of peptides  to 
immobilized aflatoxinM1-BSA. 
SPR offers several advantages over traditional immunoassay techniques for studies of binding 
interactions. It provides real-time and high throughput monitoring of KD with high sensitivity 
of detection. The two sequences had shown a better sensitivity for AFM1 than the others, 
therefore they were chosen as a recognition element for microgels assay development. 
4.2.2. Biosensing development  
The detection of AFM1-BSA was carried out by using microgels after their functionalization 
with the two novel peptides (WNDDRD(OAll)) and (WNDPRD(OAll)). Both microgels were 
obtained using similar method, for simplicity, only the procedure for one peptide is showed. 
PEGDA peptide-microparticles were synthesized in a flow focusing device. We first 
demonstrated a distribution of the peptide inside the microgels. For this, the two peptides 
were fluorescently labeled with rhodamine at the β-alanin (B) site (Rhod-BNDDRD(OAll) 
and Rhod-BNDPRD(OAll)). The fluorescence images (figure 4.3) show monodisperse 
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hydrogel particles with a uniform distribution of the labeled peptide within these particles (≈ 
9.6e-3 pg of peptide per microparticle), results that are similar to our previous work (chapter 
3).  
 
Figure 4.3: PEGDA-peptide microgel with (Rhod-BNDDRD(OAll). A) Fluorescent image of (Rhod-
BNDDRD(OAll) encapsulated; B)Phase contrast image of microgels. Scale bars are 30 µm. 
Peptide (without rhodamine) was mixed with PEGDA solution before synthesis and PEGDA 
peptide-microparticles were formed by a continuous microfluidic procedure (described in 
Chapter 3). Briefly, the pre-polymer solution containing peptide, a disperse phase, was 
injected through the central channel of the microfluidic device and oil solution with 
surfactant, a continuous phase, was injected through two side channels. Under optimized flow 
rate conditions disperse phase was sheared into monodisperse droplets by continuous phase. 
The obtained PEGDA peptide-microgels are monodisperse in size with a coefficient of 
polydispersity (PDI) < 0.003.  
PEGDA has been chosen for its resistance to protein adsorption. Peptide retains its structure 
(random-coil as it expect for small peptides) after its encapsulation, as previously reported for 
other peptides
29
 and confirmed in our previous work (chapter 3).  
Detection through fluorescence relies on the presence of a chromophore in the molecules, and 
AFs already have natural fluorescence (Figure 4.4) and can be detected directly with 
fluorescence techniques
30
.  
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Figure 4.4: Normalized ground state absorption, excitation and emission spectra for aflatoxin. 
As shown in Figure 4.5 the fluorescence intensity increased with the increase of AFM1-BSA 
concentration in both experiments. Figure 4.5  also shows a correlation between fluorescent 
signal and AFM1-BSA level (ng/Kg) in the dynamic range from 3.28 ng/Kg to 70 ng/Kg. We 
also observed that there was no obvious change of fluorescent intensity when the 
concentration of AFM1-BSA is higher than 70 ng/Kg. Thus the saturation point of AFM1-
BSA is at 70 ng/Kg in PBS. The results demonstrate the highly sensitivity of this method with 
an estimated KD of 3.66±1.55 and 6.57±3.95 pM respectively for (WNDDRD(OAll)) and 
(WNDPRD(OAll)), which obviously make a good affinity toward AFM1-BSA. Moreover, our 
system is able to detect levels of AFM1-BSA in according with the current legislative 
requirements of 50ng/L. 
 
 
Figure 4.5: Correlation between fluorescent signal and AFM1-BSA level (ng/Kg) in the sample. A) 
zoom for (WNDDRD(OAll))-AFM1-BSA binding in the range from 3.28 and 65 ng/Kg. B) zoom for 
(WNDPRD(OAll))-AFM1-BSA binding in the range from 3.28 and 65 ng/Kg. 
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Further, we synthetized microgels without peptide (a negative control) and performed the 
same protocol.  As shown in Figure 4.6, PEGDA microgels without peptide did not show a 
significant fluorescent signal compared to functionalized microgels, demonstrating the high 
specificity of peptide-microgels assay. 
 
 
Figure 4.6: AFM1 detection confocal results. A)bright field and B) fluorescent images of AFM1-
binding microparticles without peptide; C) fluorescent images of WNDDRD(OAll)-microgels binding 
and D) WNDPRD(OAll)-microgels binding. Different zoom is used, scale bar 30 µm. 
The demonstrated method is attractive alternative for AFM1 detection and quantification due 
to its specificity and reproducible properties of hydrogel particles. Importantly, our strategy is 
relatively simple and robust, and encapsulated molecules retain their structure during 
microgels processing. For the first time small molecules were used for AFMs detection and 
the functionalization of the microgels is provided directly in flow, avoiding the long and time 
consuming steps that characterize conventional techniques
31
 for microgels functionalization. 
The work reported here is an initial investigation into developing new technology in food 
contaminants detection; the work is still in progress and gives “proof-of-concept” of the 
technology for an important application.  
4.3. Conclusion 
In this work, we report a novel method for label-free and sensitive monitoring of AFM1, by 
using microfluidic functional microgels in PBS. Compared with conventional techniques, 
such as HPLC or ELISA, the peptide-microgels strategy is simple, sensitive, and specific, 
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without the need for multiple sample preparation or separation steps or a skilled operator. We 
believe that the reported system could be applicable for rapid AFM1 detection in milk, due to 
PEGDA property to prevent non-specific binding of proteins on sensing surface.  
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4.5. Experimental Section 
General Materials and Method. Poly(ethylene glycol) diacrylate (PEGDA, 700 MW), the non 
polar solvent light mineral oil and the nonionic detergent sorbitan monooleate (Span 80) were 
purchased from Sigma Aldrich. Crosslinking reagent Darocur 1173 was purchased from Ciba. 
Reagents for peptide synthesis (Fmoc-protected amino acids, resins, activation, and 
deprotection reagents) were purchased from Iris Biotech GmbH (Waldershofer Str. 49-51 
95615 Marktredwitz, Deutschland) and InBios (Naples, Italy). Solvents for peptide synthesis, 
HPLC analyses and AFM1-BSA conjugate (4-8 mol AFM per mol BSA) were purchased from 
Sigma-Aldrich; reversed phase columns for peptide analysis and the LC–MS system were 
supplied respectively from Agilent Technologies and Waters (Milan, Italy). Pooled human 
serum from healthy donors was supplied by Lonza (Life Technology Ltd, Paisley, UK). All 
chemicals were used as received. 
Microfluidic device fabrication. Microfluidic device consists of two inlets for the continuous 
and disperse phase, a narrow orifice in which the main channel and the two opposite channels 
converge, and a serpentine in which droplets were polymerized. The dimensions of the 
microchannel dimensions in the region of droplet formation is  50 × 35 × 50 (width × depth × 
length); the serpentine is 10 cm long. The microfluidic device was fabricated by combining 
the conventional photolithographic and soft-lithographic techniques. Briefly, negative 
photoresist (Mr-DWL 40 phtoresist, Microresist technology) was spun onto a silicon wafer at 
2000 rpm for 30 s to make a 35 µm thick layer of photoresist. The photoresist was baked and 
subsequently exposed using DWL 66 Fs LASER technology system (Heidelberg 
instruments). After the exposed sample had been post-baked and developed, the microfluidic 
flow focusing device master was prepared. The surface of the device mold was treated with 
tridecaﬂuoro-1,1,2,2-tetrahydrooctyl-1-trichlorosilane to facilitate the removal of a 
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polydimethyl-siloxane (PDMS, Sylgard 184, Dow Corning) replica. PDMS (10:1 polymer to 
curing agent) was poured on the patterned silicon wafer containing negative-channels. The 
PDMS-based microfluidic device was peeled off from the wafer, treated with oxygen plasma 
and bonded with a glass slide.  
Synthesis of peptides. Peptide libraries and single peptides were prepared by the solid phase 
method on a 50 μmol scale following the Fmoc strategy and using standard Fmoc-derivatized 
amino acids. Briefly, synthesis were performed on a fully automated multichannel peptide 
synthesizer Biotage® Syro Wave™. RINK AMIDE resin (substitution 0.71 mmol/g) was 
used as solid support. Activation of amino acids was achieved using HBTU-HOBt-DIEA 
(1:1:2), whereas Fmoc deprotection was carried out using a 40% (v/v) piperidine solution in 
DMF. All coupling reactions were performed for 15 minutes and deprotection reactions for 10 
minutes. 8 different amino acids (Arg, Asn, Pro, Trp, Leu, Ala, Asp and Thr) were chosen to 
build a peptide library based on their chemical and physical properties. The solid phase 
(4,55g) was split into 64 different tubes and each reactor holds the combination of the eight 
amino acids, selected for the library construction, as first and second coupling. At the end of 
coupling procedure previously reported; we obtained 64 different di-peptides that constituted 
the first peptide library. The di-peptide with the best binding properties (selected by SPR 
technique) was chosen as an initial solid phase for the second library. We prepared 4,55 g of 
the resin with the selected dipeptide immobilized on its surface by the same solid phase 
synthesis described procedures. We split this new solid phase into 64 different tubes and we 
bound a third amino acid to the activated α-carboxylic group of the second amino acid. The 
synthesis steps were the same as those followed for the first and second amino acid. At the 
end a fourth amino acid was linked to the third one by the same synthesis procedures. We 
obtained 64 tetrapeptides that had the same first and second amino acid but different third and 
fourth one and that constituted our second and last library. The best binding tetra-peptides, 
selected by SPR, were rhodaminate to monitor their entrapment in microparticles.  Lysine side 
chain amine rhodamine labeling was achieved by on-resin treatment with rhodamine 
isothiocyanate (TRITC) after removing methyltrityl (Mtt) protecting group using 1% TFA in 
DCM for 30 min. 
SPR analysis. The interactions between all 64 di-peptide and tetra-peptide were measured 
using SPR technique with SensiQ Pioneer from AlfaTest (Rome, Italy). In order to measure 
the affinity of the peptides (analyte) with the aflatoxin (ligand), AFM1-BSA conjugated was 
immobilized at a concentration of 50 µg/mL in a 10 mM acetate buffer pH 3.7 (flow 10 
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µL/min, injection time 20 min) on a COOH1 SensiQ sensor chip, using EDC/NHS chemistry 
(0.4 M EDC - 0.1 M NHS, flow 25µl/min, injection time 4 min), achieving a 7000 RU signal. 
The reactive residues were deactivated by treatment with ethanolamine hydrochloride 1 M, 
pH 8.5. In order to study the aspecific binding of peptides against BSA, the reference channel 
was prepared by activation with EDC/NHS and immobilized the only BSA at a concentration 
of 50µg/mL and reaching the same RU signal of the toxin (7000). The binding assays were 
performed at 25 μl/min, with a contact time of 4 min, all peptides were diluted in the stock 
buffer, HBS (10 mM Hepes, 150 mM NaCl, 3 mM EDTA, pH 7.4). The injection of analytes 
(100 μl) was performed at the indicated concentrations. The association phase (kon) was 
followed for 180 s, whereas the dissociation phase (koff) was followed for 300 s. The complete 
dissociation of the formed active complex was achieved by addition of 10 mM NaOH, for 60 
s before starting each new cycle. To subtract the signal of the reference channel and evaluate 
the kinetic and thermodynamic parameters of the complex, the software QDAT analysis 
package (SensiQ Pioneer, AlfaTest) was used. For tetra-peptide library binding experiment 
was conducted by Fast step injection. Fast Step is an in situ-dilution method that enables 
stepped analyte gradient injections to be performed where the concentration of sample steps 
up, or down, according to a predefined profile without reliance on dispersive mixing in a flow 
channel. The analyte concentration is modulated en route to the flow cell on-the-fly. This 
eliminates the overhead associated with multiple loading, injecting and clean up cycles 
making possible substantial reductions in experimental time and complexity. The dissociation 
of analyte can be accurately estimated from a single dissociation phase curve recorded after 
the step injection is complete. The sample throughput can be increased by >10-fold compared 
to conventional methods. In this case an analyte concentration of 1mM was used with a flow 
rate of 200 µl/min, a contact time of 20 sec and a dissociate time of 120 sec. As for bulk 
standard cycles, a 20% of sucrose was used. In all experiments kinetic parameters for all tetra- 
peptides were estimated assuming a 1:1 binding model and using QDAT software (SensiQ 
Technologies). 
Synthesis of functional microgels. Microgels were synthesized using light mineral oil 
containing nonionic surfactant Span 80 (3 wt%) as a continuous phase and poly(ethylene 
glycol)diacrylate (PEGDA) (20 wt%) with photoinitiator (0.1 wt%) and peptides (70 mg/L) as 
a disperse phase. Droplets were formed injecting prepolymer solution, disperse phase, through 
the central channel and oil solution, continuous phase, through two opposite side channels. 
The uniform PEGDA-peptide droplets were crosslinked in flow to form monodisperse 
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microgels. On average droplets were exposed to UV light for 15s. The UV light (9.8 mW) 
was filtered with DAPI microscopy filter (λ=360 nm) and focused on the device. The 
diaphragm aperture of the microscope was used to limit exposure to the serpentine region of 
the chip. After photopolymerization, microgels were collected in an eppendorf and washed 
three times with a solution of ethanol (35 v/v%) and acetone (10 v/v%) to remove the oil. The 
device inlets and outlets were connected with polyethylene tubes, and the solutions were 
injected using high-precision syringe pumps (neMesys-low pressure) to ensure a reproducible, 
stable flow. This system was mounted on an inverted microscope (IX 71 Olympus) and 
droplet formation was visualized using a 4× objective and recorded with a CCD camera 
Imperx IGV-B0620M. 
Protocol of peptides encapsulation and AFM1-BSA detection. Microgel was functionalized by 
adding the selected peptide (WNDDRD(OAll) or WNDPRD(OAll)) in the disperse phase 
prior to a microgel synthesis. Binding experiments were performed incubating peptides-
microgels with AFM1-BSA in PBS (pH 7.4) (final volume 100 µL) at room temperature for 2 
h. 5 µL of peptide-microgels were suspended in 100 µL of PBS and different concentrations 
of AFM1-BSA, ranging from 3.28 ng/Kg to 656 ng/Kg, were added. After the incubation, 
microgels were washed and their fluorescence were analyzed by confocal. The same protocol 
was used for microgels without peptide, as a negative control. 
Confocal Microscopy. Fluorescence analysis of protein-binding were performed by Leica SP5 
confocal microscope (Leica Microsystems), provided with an HCX IRAPO L 25.0×/0.95 
WATER objective and a 360 nm as selected wavelength as excitation sources for AFM1-BSA. 
Detection occurred at the 420-450 nm band. Images have been acquired with a resolution of 
1024 × 1024 pixels, zoom 1, 2.33 A.U. pinhole. All our experiments were performed at room 
temperature.  
Statistical analysis. The results of confocal experiments were analyzed by software GraphPad 
Prism version 5.04 and experimental data were expressed as mean ± standard deviation. The 
evaluation of KD was calculated by a non-linear fitting approach using GraphPad Prism 
version 5.04 software. 
Safety. Aﬂatoxins are powerful hepatotoxins and carcinogens, so great care should be taken to 
avoid personal exposure and potential laboratory contamination. All items coming in contact 
with aﬂatoxins (glassware, vials, tubes, etc.) were immersed in a 10% bleach solution for 1-2h 
before they were discarded. Pure aﬂatoxin standard was handled in a hood with extreme 
caution. 
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CHAPTER 5 
5.1. Conclusions and outlook 
Microdroplets in microfluidics has become a fast moving research area that is rapidly being 
established as a powerful tool for complex chemical and biological experiments
1
. Crucial to 
this progress has been the development of simple modules for the manipulation of droplets in 
the past 10 years. Monodisperse droplets can now be generated and manipulated on-fluidic 
chip (including heating, cooling, fusing, mixing, storing, sorting, etc.) essential for carrying 
out experiments in bulk
2
.  
Compartmentalization is clearly a powerful concept for isolating and studying single cells and 
their environments
3,4
. Microfluidic droplets are monodisperse, can be formed and analyzed at 
sufficiently large numbers, and manipulated efficiently while containing the small amounts of 
cellular material uncontaminated within those droplets. Integrated devices coupled to highly 
sensitive, ideally label-free detection methods, provide a new tool for exploring single-cell 
genomics, proteomics, and for food contaminates detection, which are research areas our 
findings contribute to.  
Droplet-based microfluidics has allowed for the study of rare tumor cells and circulating 
tumor cells (CTCs) in progressively more cell-like systems. CTCs are typically detected by 
immunomagnetic separation methods [Cellsearch], which require laborious operating steps 
and may result in the loss of target cells
5
. Our approach, contributes the field of cancer 
research providing a robust and label-free method to CTCs detection, without damaging them, 
thus opens new routes to further characterization of CTCs as key for therapeutic targets 
identification. We show that cancer cell metabolism, and more specifically, both the 
acidification of the extracellular microenvironment and the Warburg effect
6
, can be used to 
identify and count rare tumor cells and CTCs. Further work is needed to clarify how these 
results could impact in clinical routine. CTCs nature could be characterized for predicting 
cancer progression, achieving personalized cancer treatments and monitoring their efficacy. 
On the other side droplet microfluidics allows for the production of functional microparticles 
as biosensors
7,8
. The use of microfluidics has allowed the synthesis of new class of 
microparticles with novel shape, compartments and microstructures, which are very difficult 
to achieve using the conventional bulk emulsification methods. Our work provides innovative 
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advances in gel particle functionalization and opens new possibilities for direct molecules 
detection in complex fluids. We show how the compartmentalization of small analytes and the 
choose of polyethylene glycol (PEG), for its antifouling property, improve the sensitivity and 
the specificity of the detection system. We developed a label-free strategy to detect aflatoxin. 
It is  typically screened by chromatographic methods, which need multiple separation steps of 
the sample and require skilled operators
9
. Microparticles strategy is simple and sensitive and 
could be applicable for direct aflatoxin detection in milk thanks to PEG property to prevent 
non-specific binding of protein on sensing surface. More works in this area could be directed 
towards its clinical integration forward from current “proof-of-concept”. The next step 
therefore is to use this method to aflatoxin detection directly in milk.  
The systems we described may provide some improving in the actual research on cancer and 
food contaminants screening. The using of microfluidics has followed for the develop of 
robust, label-free, sensitive and high-throughput platforms which we hope will be used in the 
near future to improve the quality of life. 
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